PMID- 33468769
OWN - NLM
STAT- MEDLINE
DCOM- 20210121
LR  - 20210121
IS  - 0385-0684 (Print)
IS  - 0385-0684 (Linking)
VI  - 47
IP  - 13
DP  - 2020 Dec
TI  - [Long-Term Recurrence-Free Survival in a Patient Who Received Chemotherapy for 
      Multiple Metastases of Rectal Cancer Including the Lesser-Curvature Lymph Node 
      Metastasis-A Case Report].
PG  - 1969-1971
AB  - A 49-year-old man was preoperatively diagnosed with rectosigmoid carcinoma, 
      c-T4a, N3, M1b, Stage Ⅳb. On CT, lymph node swelling outside that area, including 
      lesser-curvature lymph nodes(LNS), and liver metastases were seen. Laparoscopic 
      high anterior resection was performed with the aim of local control. 
      Additionally, D3 dissection and LNS sampling were performed. The tumor had 
      invaded the bladder wall, and removed LNS were positive for metastasis. The final 
      diagnosis was f-T4b, N3, M1b, Stage Ⅳb. One month after surgery, a CV port was 
      implanted, and chemotherapy was initiated for unresectable cancer. The regimen 
      was capecitabine and oxaliplatin(CAPOX)plus bevacizumab(BEV). After 5 courses, 
      the patient was hospitalized for a CV thrombus that had occurred, and his 
      chemotherapy was withdrawn for approximately 1 month while he was receiving 
      antithrombotic therapy. After discharge, BEV was discontinued, and he received 
      CAPOX alone. Bleeding from a pituitary adenoma was seen after a total of 19 
      courses. He was hospitalized for 2 months for the treatment, including surgery. A 
      clinical complete response was determined based on CT and PET-CT performed after 
      chemotherapy had been withdrawn for approximately 3 months. For approximately 1 
      year since the chemotherapy was discontinued, progression-free survival has been 
      maintained.
FAU - Yamada, Erika
AU  - Yamada E
AD  - Dept. of Gastrointestinal and Pediatric Surgery, Tokyo Medical University.
FAU - Enomoto, Masanobu
AU  - Enomoto M
FAU - Ishizaki, Tetsuo
AU  - Ishizaki T
FAU - Mazaki, Junichi
AU  - Mazaki J
FAU - Wada, Takahiro
AU  - Wada T
FAU - Watanabe, Mitsuru
AU  - Watanabe M
FAU - Kasahara, Kenta
AU  - Kasahara K
FAU - Ohno, Yuki
AU  - Ohno Y
FAU - Takano, Yuki
AU  - Takano Y
FAU - Nagakawa, Yuichi
AU  - Nagakawa Y
FAU - Katsumata, Kenji
AU  - Katsumata K
FAU - Tsuchida, Akihiko
AU  - Tsuchida A
LA  - jpn
PT  - Case Reports
PT  - Journal Article
PL  - Japan
TA  - Gan To Kagaku Ryoho
JT  - Gan to kagaku ryoho. Cancer & chemotherapy
JID - 7810034
RN  - 6804DJ8Z9U (Capecitabine)
SB  - IM
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - Capecitabine/therapeutic use
MH  - Humans
MH  - Lymph Nodes
MH  - Lymphatic Metastasis
MH  - Male
MH  - Middle Aged
MH  - *Positron Emission Tomography Computed Tomography
MH  - *Rectal Neoplasms/drug therapy/surgery
EDAT- 2021/01/21 06:00
MHDA- 2021/01/22 06:00
CRDT- 2021/01/20 05:44
PHST- 2021/01/20 05:44 [entrez]
PHST- 2021/01/21 06:00 [pubmed]
PHST- 2021/01/22 06:00 [medline]
PST - ppublish
SO  - Gan To Kagaku Ryoho. 2020 Dec;47(13):1969-1971.